Analyzing Bristol-Myers Squibb Co. (BMY) After Recent Trading Activity
Bristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on
Bristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Bristol-Myers Squibb Co.’s recently made public that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Bristol-Myers Squibb Co.’s recently made public that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Bristol-Myers Squibb Co.’s recent filing unveils that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0